Prospectus Filed Pursuant to Rule 424(b)(3) (424b3)
June 15 2018 - 5:14PM
Edgar (US Regulatory)
Filed pursuant
to Rule 424(b)(3)
Registration No. 333-222967
PROSPECTUS SUPPLEMENT NO. 2
750,002 Common Shares
Auris Medical Holding AG
Common Shares
This Prospectus Supplement No. 2 (this “Prospectus
Supplement”) amends and supplements our Prospectus dated May 10, 2018 (the “Prospectus”), which forms a part
of our Registration Statement (our “Registration Statement”) on Form F-1 (Registration No. 333-222967). This Prospectus
Supplement is being filed to amend and supplement the information included or incorporated by reference in the Prospectus with
the information contained in this Prospectus Supplement. The Prospectus and this Prospectus Supplement relate to the resale of
up to 750,002 of our common shares issuable upon exercise of certain outstanding warrants.
This Prospectus Supplement includes information
from our Current Report on Form 6-K, which was filed with the Securities and Exchange Commission on June 15, 2018.
This Prospectus Supplement should be read
in conjunction with the Prospectus that was previously delivered, except to the extent that the information in this Prospectus
Supplement updates and supersedes the information contained in the Prospectus.
Neither the Securities and Exchange
Commission nor any state securities commission has approved or disapproved of these securities or passed upon the adequacy or accuracy
of this Prospectus Supplement or the Prospectus. Any representation to the contrary is a criminal offense.
The date of this Prospectus Supplement is
June 15, 2018.
Filing on Form F-1
On June 15, 2018, Auris Medical Holding
AG (the “Company”) filed a Registration Statement on Form F-1 (the “Registration Statement”) in connection
with a proposed public offering of 14,256,198 common shares (including the underwriters’ option to purchase additional common
shares to cover over-allotments) and warrants to purchase common shares.
Auris Medical (NASDAQ:EARS)
Historical Stock Chart
From Aug 2024 to Sep 2024
Auris Medical (NASDAQ:EARS)
Historical Stock Chart
From Sep 2023 to Sep 2024